Dr. Mark William Russo, MD

Dr. Russo practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Russo's NPI, 1588745392, was assigned on October 18, 2006. Dr. Russo graduated from Icahn School of Medicine at Mount Sinai in 1992. Dr. Russo holds North Carolina license 9500209.

Dr. Russo's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Russo's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Russo is also affiliated with Atrium Health Pineville. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Russo to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russo practices, 7 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Russo's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Russo is licensed in North Carolina.

CMS data shows 252 Medicare services from Dr. Russo across 6 procedure codes in 2024, for 199 Medicare patients. Medicare paid $15,066 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Dr. Russo in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Russo's median patient age at 68, with 51% women.

In 2024, Dr. Russo wrote 1,238 Medicare Part D claims for 194 patients. 85% of them were for generic drugs. CMS names the drug for 1,111 of them, across 20 drugs with 11 or more claims each, at $621,410 in total drug cost. In 2023, CMS named 1,193 claims across 22 drugs.

Dr. Russo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Russo as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 71 papers to Dr. Russo, published from 2011 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Liver Cirrhosis and Liver. Dr. Russo has published most often in Hepatology. Dr. Russo's most frequent co-authors are Herbert L. Bonkovsky, MD, Andrew Scott Delemos, MD and Lon Brian Eskind, MD.

Dmand AI links Dr. Russo to 1 clinical trial. Conditions studied include Liver Cirrhosis, Biliary and Cholestasis, Intrahepatic.

CMS Open Payments shows 502 general payments to Dr. Russo from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Gilead Sciences, Inc. paid the most, $175,178. It also lists 5 research payments totaling $2,300 from 2021 to 2022.

Dr. Russo graduated from Icahn School of Medicine at Mount Sinai in 1992.